Login

Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell. 00:10:00

Share On Facebook Share On Twitter

Martin J Schroeter is Chairman/CEO at Kyndryl Holdings Inc. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
AboitizPower CEO Manny Rubio discusses navigating the company through the pandemic and investing in renewable energy.
00:10:00
taken two public and realized over a billion dollars in exits|Gil Elbaz,Founding Partner,TenOneTen Ventures
00:10:00
Navigating Fed Policy and Inflation Challenges - Ben and Curtis | Hilltop Wealth Advisors
00:10:00
Exploring Far Resources: Promising Lithium Projects in Manitoba
00:10:00
Let's Talk About Your Organization's Retirement Plan | Rene Bruner - Advisor of smith bruer advisors
00:10:00
Values-Aligned Investing: Understanding SRI and ESG
00:10:00
Denali Group: Expert Dental Office Consulting for Stress-Free Practice Development
00:00:00
David Solomon, CEO of Pharnext
00:10:00
Fragmentos de Conversación y Reflexiones en Música
00:10:00
Lithium Chile's Expansion and Strategic Plans: Interview with Michelle Deo
00:10:00
Shibani Kurian Presents Kotak Focused Equity Fund: A Strategy for Select Focus Investing | Shibani Kurian, Head of Research & Equity Fund Manager, Kotak Mutual Fund
00:10:00
Crystal Peak Minerals: Unlocking Premium SOP Opportunities in Utah

© 2026 Nehu